Fisher Scientific has named Matthew Friel as senior vice president of corporate development.
According to the company, Friel was most recently with GenTek, where he served as executive vice president of finance and business development, as well as vice president and CFO. Before this, he was a managing director at Latona Associates, a merchant banking firm acting as both a principal and an advisor in mergers, acquisitions, divestitures, and project-financing transactions.
Friel has also served as an assistant director in the mergers and acquisitions group of Barclays de Zoete Wedd, the investment banking arm of Barclays Bank, said Invitrogen. He has a BS in business administration from Georgetown University, and an MBA from Harvard Business School.
Acuity Pharmaceuticals said this week that it has formed its scientific advisory board.
Members of the board include Alexander Brucker, professor of ophthalmology at the University of Pennsylvania Scheie Eye Institute; Lloyd Paul Aiello, associate professor of ophthalmology at Harvard Medical School and head of the Section of Eye Research at the Joslin Diabetes Center; Alan Gewirtz, professor of medicine, and pathology, and laboratory medicine at the University of Pennsylvania School of Medicine; Baruch Kuppermann¸ professor of ophthalmology at the University of California, Irvine; Richard McCloskey, vice president of medical technology at Johnson & Johnson Development Corporation; Lawrence Singerman, clinical professor of ophthalmology at Case Western Reserve University School of Medicine and professor of clinical ophthalmology at the Bascom Palmer Eye Institute of the University of Miami; Jason Slakter, vitreoretinal surgeon and macular disease specialist at the Manhattan Eye, Ear, and Throat Hospital and clinical professor of ophthalmology at NYU School of Medicine; William Tasman, chairman of the department of ophthalmology at Jefferson Medical College and ophthalmologist-in-chief of Wills Eye Hospital; Lawrence Yannuzzi, professor of clinical ophthalmology at Columbia University Medical School; and Yihai Cao, professor and team leader of the Microbiology and Tumor Biology Center at the Karolinska Institute.
Additionally, Acuity said that Julia Haller, Katharine Graham professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute, has joined the company as clinical consultant and advisor.
The National Academy of Sciences announced this week the election of 72 new members, including Craig Mello, a University of Massachusetts Medical School investigator and RNAi pioneer.
Invitrogen said this week that it has named Mark Gardner as its chief marketing officer.
Gardner has been with Invitrogen since 2003, serving in such roles as vice president of process development and vice president of commercial marketing. He previously worked for General Electric Medical Systems in its information technologies division.